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Periodontitis is a prevalent chronic inflammatory disease triggered by a synergistic and dysbiotic microbiota present in the oral
biofilm. This in vitro study is aimed at evaluating the regulation of cyclooxygenase (COX)2 expression and production by the
periodontopathogen Filifactor alocis in human gingival fibroblastic (HGF-1) and monocytic (THP-1) cells and also at
investigating the underlying cellular pathway mechanisms. HGF-1 and THP-1 cells were exposed either to F. alocis or to the
proinflammatory cytokine tumor necrosis factor alpha (TNFα) for 1 and 2 d to examine the COX2 expression by qPCR. COX2
protein levels were evaluated by ELISA in F. alocis-stimulated cells. Both types of cells were also stimulated with a blocking toll-
like receptor (TLR)2 antibody or specific inhibitors against MAPKs. F. alocis significantly (p < 0:05) increased COX2 at both
transcriptional and protein levels in both HGF-1 and THP-1 cells. Moreover, the stimulatory effect of F. alocis on COX2 was
more pronounced in HGF-1 cells in comparison to THP-1 cells. F. alocis upregulated the COX2 expression in a dose-dependent
manner in both type cells at 1 d. TNFα also significantly (p < 0:05) increased the COX2 expression in both cells. After
preincubation of HGF-1 and THP-1 cells either with a neutralizing anti-TLR2 antibody or with specific MAPK inhibitors, the F.
alocis-upregulated COX2 expression was significantly (p < 0:05) suppressed at 1 d. Our in vitro study provides original evidence
that F. alocis stimulates COX2 production in fibroblastic and monocytic cells through TLR2 and MAPK mechanisms, suggesting
a role of this periodontopathogen in the etiopathogenesis of periodontitis.
1. Introduction
Periodontitis is a chronic inflammatory disease triggered by a
synergistic and dysbiotic microbiota present in the oral
biofilm. Periodontopathogenic bacteria and their products
activate the host immune response leading to an overproduc-
tion of proinflammatory mediators. The progression of
periodontitis is associated with a sustained and excessive
immune-inflammatory response resulting in irreversible
destruction of the periodontal supporting tissues and, even-
tually, in tooth loss [1, 2]. In the periodontal tissues, both res-
ident and infiltrating immune cells such as fibroblasts,
monocytes, and macrophages are responsible for the increase
in proinflammatory mediators like interleukin- (IL-) 1β,
tumor necrosis factor alpha (TNFα), cyclooxygenase
(COX)2, and matrix metalloproteinases. These mediators
play an important role in the hard and soft tissue destruction
by modulating the inflammatory cascade in periodontitis [3].
COX exists in two isoforms: COX1 and COX2. COX1 is
constitutively expressed in many cells and tissues and is
mainly involved in the maintenance of tissue homeostasis
[4]. In contrast, COX2 is an inducible enzyme expressed by
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cells during inflammatory processes [4]. COX2 is induced by
proinflammatory and infectious agents and is responsible for
the conversion of arachidonic acid into prostaglandin
(PG)E2 [5], which is actively involved in tissue damages by
changing the connective tissue metabolism and by enhancing
osteoclastic bone resorption, showing an evident association
with the tissue destruction during periodontal disease
progression [6, 7]. COX2 plays an important role in the
inflammatory process in periodontal diseases. Increased
levels of COX2 and PGE2 have been demonstrated in saliva,
gingiva, and gingival crevicular fluid of patients with peri-
odontal disease [8–13].
Some studies have shown a strong association between
Filifactor alocis and periodontitis [14, 15]. This periodonto-
pathogen is a Gram-positive anaerobic bacterium that has
been detected in a higher number in saliva as well as in supra-
gingival and subgingival biofilm of periodontal patients as
compared to healthy subjects [15–18]. F. alocis has a high
prevalence in periodontitis that could be attributed to its
ability to invade periodontal cells and tissues, to resist
oxidative stress and to stimulate, alone or together with
periodontal pathogens, the secretion of proinflammatory
cytokines [19, 20]. Although F. alocis has been associated
with periodontitis, no previous study has examined whether
this periodontopathogen modulates the expression of
COX2 by professional and accessory immune cells. Thus,
the aim of the present study was to evaluate the effect of
F. alocis on the COX2 expression and production by mono-
cytic and fibroblastic cells and to unravel the underlying
pathway mechanisms.
2. Materials and Methods
2.1. Culture and Treatment of Cells. Human gingival fibro-
blast cell line (HGF-1) (ATCC® CRL-2014™, LGC Standards,
Wesel, Germany) and human acute monocytic leukemia cell
line (THP-1) (CLS Cell Lines Service, Eppelheim, Germany)
were used. HGF-1 was seeded on 6-well cell culture plates
(5 × 104 cells/well) and grown to 80% confluence in Dulbec-
co’s minimal essential medium (DMEM, Invitrogen, Karls-
ruhe, Germany) supplemented with 10% fetal bovine serum
(FBS, Invitrogen), 100 units penicillin, and 100μg/ml strep-
tomycin (Invitrogen). THP-1 was seeded once their concen-
tration reached 1 × 106 cells/ml using RPMI 1640 medium
(Invitrogen) supplemented with 10% FBS, 100 units penicil-
lin, and 100μg/ml streptomycin. Both types of cells were
grown at 37°C in a humidified atmosphere of 5% CO2, and
every other day, the cell culture medium was changed. One
day prior to the experiments, the FBS concentration was
reduced to 1%.
The oral pathogenic bacterium F. alocis ATCC 35896™
was used to stimulate the cells at different concentrations
(optical density (OD): 0.05, 0.1, and 0.2) as in our previous
study [21]. F. alocis was precultivated in an anaerobic atmo-
sphere on Schaedler agar plates (Oxoid, Basingstoke, UK) for
48 h and, then, suspended in phosphate-buffered saline
(OD660nm= 1, equivalent to 1:2 × 109 bacterial cells/ml). Sub-
sequently, the bacteria suspension was exposed twice to
ultrasonication (160W for 15min) resulting in total bacterial
killing. In order to unravel intracellular signaling mecha-
nisms by which F. alocis could possibly modulate COX2
expression, cells were preincubated with specific inhibitors
of different pathways (MEK1 and MEK2: U0126, 10μM;
P38: SB203580, 10μM; pyrrolidine dithiocarbamate: PDTC,
10μM; and JNK inhibitor II: SP600125, 10μM; all from
Calbiochem, San Diego, CA, USA), 1 h prior to the F. alocis
stimulation. Furthermore, cells were also preincubated with
a blocking anti-human toll-like receptor (TLR) 2 monoclonal
antibody (10μg/ml; eBioscience, San Diego, CA, USA)
45min prior to the F. alocis stimulation. Moreover, in order
to mimic inflammatory conditions in vitro, cells were treated
with human recombinant tumor necrosis factor (TNF)α
(Biomol, Hamburg, Germany), which is one of the key
inflammatory mediators in the pathogenesis of the periodon-
tal diseases. TNFα was applied at a concentration of 1 ng/ml,
which is in the range of levels usually found in the gingival
crevicular fluid (GCF) of periodontally diseased patients
and which has been used by other investigators [22, 23].
Untreated cells served as a control.
2.2. Scanning Electron Microscopy. Scanning electron
microscopy images were taken to visualize the attachment
of F. alocis ATCC 35896 on fibroblasts. The cells were cul-
tured on glass slides until a monolayer was formed and
thereafter exposed to F. alocis for 1 h. Samples were fixed
with 2% glutaraldehyde in 0.1M cacodylate buffer for
30min, washed twice with cacodylate buffer, and dehy-
drated using a 10% graded ethanol series (10min each
concentration). At the Center of Electron Microscopy,
University Hospital of Jena, Germany, critical point drying
was performed, and samples were sputter-coated with gold
and examined with a ZEISS LEO-1530 Gemini (Carl Zeiss
NTS, Oberkochen, Germany) equipped with a field emission
electron gun at 10 keV.
2.3. Real-Time PCR. Total RNA was extracted by using a
RNA extraction kit (RNeasy Mini Kit, Qiagen, Hilden,
Germany) following the manufacturer’s protocol. Subse-
quently, RNA concentration was verified by a spectropho-
tometer (NanoDrop ND-2000, Thermo Fisher Scientific,
Wilmington, DE, USA), and 500ng of total RNA was tran-
scribed to cDNA using the iScript™ Select cDNA Synthesis
Kit (Bio-Rad Laboratories, Munich, Germany) at 42°C for
90min followed by 85°C for 5min, according to the manu-
facturer’s instructions. The gene expression of COX2 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
an endogenous control was evaluated by quantitative RT-
PCR by using an iCycler iQ5 Real-Time PCR Detection Sys-
tem (Bio-Rad). A 25μl PCR reaction mixture was prepared
containing 1μl of cDNA, 12.5μl of SsoAdvanced™Universal
SYBR® Green Supermix (Bio-Rad), 2.5μl of primers, and 9μl
RNase-free water. The thermal protocol of the PCR reaction
was 95°C for 5min, followed by 40 cycles of denaturation at
95°C for 10 s and combined annealing/extension at 60°C for
30 s. This analysis was performed in triplicate. The data anal-
ysis of gene expression was performed using the comparative
threshold cycle (CT) method.
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2.4. ELISA. HGF-1 or THP-1 cell lysates were used to evalu-
ate the levels of COX2 by using commercially available sand-
wich enzyme-linked immunoassay (ELISA) detection kit
(DYC4198-2; human/mouse Total COX2 ELISA with Duo-
Set, R&D Systems Europe, Abingdon, United Kingdom)
according to the manufacturer’s instructions. The COX2
concentration was measured by spectrophotometry using a
microplate reader (PowerWave X, BioTek Instruments,
Winooski, VT, USA) at 450nm with wavelength correction
at 540nm. Total protein concentration was measured using
Pierce BCA Protein Assay Kit (23227, Thermo Fisher Scien-
tific, Pierce Biotechnology, Rockford, USA) and used to nor-
malize the data.
2.5. Statistical Analysis. Statistical analysis was performed
using the software IBM SPSS Statistics 22. The mean
values and standard errors of the mean (SEM) were calcu-
lated. For statistical analysis, parametric (ANOVA
followed by post hoc Dunnett’s and Tukey’s tests) and
nonparametric tests (Wilcoxon and Mann-Whitney U
tests) were used. Significant differences between groups
were considered at p value < 0.05. All experiments were
performed in triplicate and repeated at least twice.
3. Results
3.1. F. alocis Accumulation on Gingival Fibroblast.
Figures 1(a) and 2(b) show F. alocis and its capability to
attach to periodontal fibroblastic cells.
3.2. Regulation of COX2 by F. alocis in HGF-1 Cells. First, we
investigated the regulation of COX2 in the presence and
absence of the periodontopathogen F. alocis in HGF-1
cells. As shown in Figure 2(a), F. alocis caused a signifi-
cant (p < 0:05) increase in the constitutive COX2 expres-
sion at 1 and 2d, as analyzed by qPCR. Furthermore,
the stimulatory effect of F. alocis on the COX2 expression
was dose-dependent at d, with the highest COX2 expres-
sion at the highest concentration of F. alocis
(Figure 2(b)). The stimulatory action of F. alocis on
COX2 was also found at the protein level at 1 d. COX2
protein levels were significantly (p < 0:05) higher in cell
lysates from F. alocis-stimulated HGF-1 cells as compared
to unstimulated control cells, as determined by ELISA
(Figure 2(c)). Interestingly, the proinflammatory cytokine
TNFα also significantly (p < 0:05) increased the COX2
expression in HGF-1 cells at 1 d and 2d (Figure 2(d)).
3.3. Regulation of COX2 by F. alocis in THP-1 Cells. Next, we
sought to evaluate the influence of F. alocis on COX2 expres-
sion and protein levels in THP-1 cells. Like in HGF-1 cells, F.
alocis caused a significant (p < 0:05) upregulation of COX2 in
THP-1 cells at 1 d and 2d, as demonstrated in Figure 3(a).
Moreover, the upregulation of COX2 expression by F. alocis
was also dose-dependent in THP-1 cells. Again, the highest
COX2 expression was observed at the highest concentration
of F. alocis, and the protein levels were also paralleled by
the gene expression levels of COX2 (Figures 3(b) and 3(c)).
Following stimulation with TNFα, THP-1 cells showed a sig-
nificantly (p < 0:05) increased COX2 expression at 1 d but
not 2 d (Figure 3(d)).
3.4. Involvement of TLR2 and Signaling Pathways in the
Actions of F. alocis. Next, we sought to elucidate whether
the stimulatory effects of F. alocis on COX2 expression were
mediated through TLR2. Interestingly, when HGF-1 and
THP-1 cells were preincubated with an anti-TLR2 blocking
antibody, the stimulatory effect of F. alocis on COX2 was sig-
nificantly (p < 0:05) abolished at 1 d, as shown in Figures 4(a)
and 4(b). Furthermore, we examined the involvement of
intracellular pathways typically associated with inflamma-
tory processes. HGF-1 and THP-1 cells were preincubated
with specific inhibitors for MEK1/MEK2 (U0126), p38
(SB203580), NF-κB (PDTC), and JNK (SP600125) signaling,
which resulted in a significant (p < 0:05) reduction of the F.
alocis-induced COX2 expression for each of these inhibitors
at 1 d (Figures 4(c) and 4(d)).
4. Discussion
Our study provides original evidence that the putative oral
pathogen F. alocis is capable of inducing COX2 at transcrip-
tional and protein levels in human fibroblastic and mono-
cytic cells through TLR2 and MAPK signaling, suggesting a
role of F. alocis in the etiopathogenesis of periodontal dis-
eases. Interestingly, the stimulatory effect of F. alocis on
COX2 was more pronounced in fibroblasts as compared to
the monocytic cells, which emphasizes the significance of
(a) (b)
Figure 1: (a, b) Scanning electron microscopy images of F. alocis attached to fibroblastic cells. Scale bars: 5 μm (a) and 500 nm (b).
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periodontal fibroblasts as accessory inflammatory cells in
periodontal inflammation.
The human oral microbiome comprises of more than 700
prokaryote species, and one of the periodontopathogens is F.
alocis [24]. F. alocis is a Gram-positive, asaccharolytic,
obligate anaerobic microorganism with a high prevalence in
periodontal diseases [25]. Due to its virulence factors, F. alo-
cis has the capacity to resist to oxidative stress, form biofilms,
interact with other periodontopathogens, and produce prote-
ases. Furthermore, periodontopathogens, such as F. alocis,
are able to invade gingival cells and tissues, as the pocket epi-
thelium is ulcerated in periodontitis, and can therefore get
into the subepithelial blood vessels. As a consequence, infec-
tions with F. alocis result in the activation of the host immune
response and, subsequently, the release of proinflammatory
mediators by immunoinflammatory cells [19, 20, 26]. Ulti-
mately, the dysregulated and excessive immunoinflamma-
tory processes lead to soft tissue damage and alveolar bone
resorption. COX2 is a key molecule of periodontal inflamma-
tion. Increased COX2 levels were found at sites of gingival or
periodontal inflammation, and its expression has been shown
to be associated with the severity of the disease [10, 11, 27].
High COX2 levels in inflamed gingival tissues leads, in turn,
to elevated PGE2 levels, which then further mediates the soft
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Figure 2: (a) Expression of COX2 in the presence and absence of F. alocis (OD660: 0.1) in HGF-1 cells at 1 d and 2 d, as analyzed by qPCR.
Mean ± SEM (n = 18). ∗Significant (p < 0:05) difference between groups. (b) Stimulation of COX2 expression by various concentrations of
F. alocis (OD660: 0.05, 0.1, and 0.2) in HGF-1 cells at 1 d, as analyzed by qPCR. Unstimulated cells served as the control. Mean ± SEM
(n = 6). ∗Significantly (p < 0:05) different from control. (c) COX2 protein level in lysates of HGF-1 cells in the presence and absence of
F. alocis (OD660: 0.1) at 1 d, as analyzed by ELISA. Mean ± SEM (n = 12). ∗Significant (p < 0:05) difference between groups. (d)
Expression of COX2 in the presence and absence of TNFα (1 ng/ml) in HGF-1 cells at 1 d and 2 d, as analyzed by qPCR. Mean ± SEM
(n = 26). ∗Significant (p < 0:05) difference between groups.
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and hard tissue destruction [28], which highlights the impor-
tance of COX2 in the etiopathogenesis of periodontitis. Con-
sequently, COX2 inhibitors have been evaluated for their
adjunctive benefit in the treatment of periodontal diseases
[29–31]. To date, no study has focused on the effect of F. alo-
cis on the COX2 regulation, which could mediate, at least in
part, the pathogenic actions of this microorganism on peri-
odontal tissues. In this context, we sought to analyze what
role structural resident cells of the periodontium, e.g., gingi-
val fibroblasts, play as compared to professional inflamma-
tory cells, e.g., monocytic cells.
Our data demonstrates for the first time that F. alocis
upregulates the COX2 expression and increases the protein
synthesis in both HGF-1 and THP-1 cells, suggesting that
this putative pathogen also contributes to the elevated levels
of COX2 in gingival tissues of periodontitis patients.
Remarkably, the fibroblastic cells showed a more pro-
nounced inflammatory response to F. alocis as compared to
the monocytic cells, demonstrating the critical role of peri-
odontal cells in the etiopathogenesis of periodontal diseases.
It would be very interesting to also examine the effect of F.
alocis on COX2 in gingival epithelial cells in future studies.
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Figure 3: (a) Expression of COX2 in the presence and absence of F. alocis (OD660: 0.1) in THP-1 cells at 1 d and 2 d, as analyzed by qPCR.
Mean ± SEM (n = 18). ∗Significant (p < 0:05) difference between groups. (b) Stimulation of COX2 expression by various concentrations of
F. alocis (OD660: 0.05, 0.1, and 0.2) in THP-1 cells at 1 d, as analyzed by qPCR. Unstimulated cells served as the control. Mean ± SEM
(n = 18). ∗Significantly (p < 0:05) different from the control. (c) COX2 protein level in lysates of THP-1 cells in the presence and
absence of F. alocis (OD660: 0.1) at 1 d, as analyzed by ELISA. Mean ± SEM (n = 18). ∗Significant (p < 0:05) difference between groups.
(d) Expression of COX2 in the presence and absence of TNFα (1 ng/ml) in THP-1 cells at 1 d and 2 d, as analyzed by qPCR. Mean ±
SEM (n = 12). ∗Significant (p < 0:05) difference between groups.
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Interestingly, other investigators have observed that IL-1β
and Aggregatibacter actinomycetemcomitans as well as Tan-
nerella forsythia stimulate the COX2 expression in gingival
fibroblasts, which is in agreement with our findings for TNFα
and F. alocis [28]. We have previously demonstrated that
Fusobacterium nucleatum is able to modulate COX2 levels
in human periodontal ligament fibroblasts [32]. In summary,
these observations suggest that periodontopathogens may
use COX2 for their detrimental effects on periodontal cells
and tissues.
Preincubation with a blocking TLR2 antibody resulted in
a significant inhibition of the F. alocis-induced COX2 expres-
sion in HGF-1 and THP-1 cells, suggesting that F. alocis is
interacting with this TLR for its inflammatory actions. Also,
preincubation of HGF-1 and THP-1 cells with specific
blockers against MAPK signaling, such as MEK1/MEK2,
p38 MAPK, NF-κB, and JNK, caused an inhibition of the F.
alocis-upregulated COX2 expression, indicating that these
signaling pathways are involved in the regulation of COX2
by F. alocis in fibroblastic and monocytic cells. Recently, it
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Figure 4: COX2 gene expression in response to F. alocis (OD660: 0.1) in the presence and absence of anti-TLR2 blocking antibody in HGF-1
(a) and THP-1 (b) cells at 1 d, as analyzed by qPCR. Mean ± SEM (n = 3). ∗Significant (p < 0:05) difference between groups. COX2 gene
expression in response to F. alocis (OD660: 0.1) in the presence and absence of specific inhibitors against MEK1/MEK2 (U0126; 10μM),
p38 (SB203580; 10 μM), NF-κB (PDTC; 10μM), and JNK (SP600125; 10μM) in HGF-1 (c) and THP-1 (d) cells at 1 d, as analyzed by
qPCR. Mean ± SEM (n = 3). ∗Significant (p < 0:05) difference between groups.
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has been demonstrated that interaction of F. alocis with neu-
trophils through TLR2 and subsequent activation of ERK1/2
and p38MAPK pathways results in granule exocytosis as well
as random and directed migration [16], which is in accor-
dance with the observation that F. alocis exploits TLR2 and
MAPKs for its effects. However, additional pathways could
be involved in the actions of F. alocis on COX2 and should
be studied in further investigations. In our experiments, a
lysate of F. alocis was applied and the protease activity was
still maintained. The used concentration of the bacterial
lysate was also applied in previous studies on other periodon-
topathogens [32–34]. Although the knowledge on the F. alo-
cis cell wall components is still limited, it could be assumed
that lipoteichoic acid and/or peptidoglycan, which are pres-
ent on the cell wall of Gram-positive bacteria, can directly
stimulate fibroblasts or monocytes. Additional virulence fac-
tors of F. alocis could also have been contributed to the stim-
ulatory effects of this microorganism on COX2 in our cells.
Therefore, other receptors in addition to TLR2 may also have
been implicated in the COX2 regulation.
In order to better understand the pathogenic role of F.
alocis in the etiopathogenesis of periodontal diseases, this
periodontopathogen was selected for our study. The classical
periodontopathogens P. gingivalis and F. nucleatum were
also shown to upregulate COX2, which was used as a target
in our study, in immunoinflammatory and periodontal fibro-
blastic cells, emphasizing again the key role of COX2 in the
pathogenesis of periodontitis [32, 35]. Since periodontitis is
a polymicrobial disease, the effect of F. alocis in combination
with other periodontopathogens should also be considered in
future studies.
In one of our previous and recent study, we have used
similar methodology but different experiments to evaluate
the effect of F. alocis on the regulation of the collagenase
MMP-1 in HGF-1 and THP-1 cells. We have demonstrated
for the first time that F. alocis significantly increases the
expression and protein synthesis of MMP-1 in both HGF-1
and THP-1 cells [21]. Interestingly, our results show original
evidence that F. alocismay contribute to periodontal destruc-
tion through MMP-1 and to periodontal inflammation
through COX2, demonstrating its role in two different stages
of the periodontal disease process.
In summary, our in vitro study provides novel evidence
that F. alocis upregulates COX2 at both transcriptional and
protein levels through TLR2 and MAPK signaling mecha-
nisms in human gingival fibroblastic and monocytic cells,
suggesting that F. alocis may play a role in periodontal dis-
ease initiation and progression, therefore contributing to
periodontal inflammation and tissue destruction. Moreover,
the stimulatory action of F. alocis on COX2 was more pro-
nounced in gingival fibroblasts as compared to the monocytic
cells, underlining the critical role of these fibroblasts as acces-
sory inflammatory cells in periodontal inflammation.
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